NORTHERN TRUST CORP - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 30 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2022$70,000
-27.1%
330,792
-1.7%
0.00%
Q1 2022$96,000
+43.3%
336,399
+37.1%
0.00%
Q4 2021$67,000
-40.7%
245,3990.0%0.00%
Q3 2021$113,000
-23.6%
245,3990.0%0.00%
Q2 2021$148,000
-11.9%
245,399
-0.5%
0.00%
Q1 2021$168,000
+3260.0%
246,542
+1706.7%
0.00%
Q4 2020$5,000
-64.3%
13,646
-52.1%
0.00%
Q3 2020$14,000
+27.3%
28,507
+38.3%
0.00%
Q2 2020$11,000
+57.1%
20,6180.0%0.00%
Q1 2020$7,00020,6180.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 306,479$87,0000.01%
1620 INVESTMENT ADVISORS, INC. 15,000$4,0000.00%
Landmark Financial Advisors, LLC 24,200$6,0000.00%
MSD Partners, L.P. 116,430$33,0000.00%
IFP Advisors, Inc 17,650$58,0000.00%
Jacobi Capital Management LLC 18,500$5,0000.00%
Focused Wealth Management, Inc 500$00.00%
JANE STREET GROUP, LLC 281,700$80,0000.00%
UBS Group AG 79,851$23,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders